Harvard Bioscience, Inc. (HBIO) has a market capitalization of $25.67M and trades at $5.74. The 52-week range is 2.8-9.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-12.80, annual revenue of $86.55M.
The stock has a beta of 1.50, operates in the Healthcare sector.
